AT-31 BIO Inc.
other
www.at31bio.comDaegu, South KoreaAbout
AT-31 BIO Inc. aims to discover new drug candidates and develop innovative drugs that contribute to a healthy, happy society by overcoming diseases caused by dysfunctional immune systems. Currently, we are conducting empirical studies using cutting-edge research techniques on the immunosuppressive efficacy. We are also conducting preclinical studies using animal disease models to explore and establish indications for our potential drug candidates. Through these research approaches, we hope to open new horizons in the prevention and treatment of autoimmune diseases, transplant rejection, and hypersensitivity immune diseases, which represent unmet medical needs.
What is your business/industry sector?